A Long-Term Follow-up Study of the Severe Parkinson's Disease Patients Administered the IPS101A Gene Therapy Product.

NCT07629115 · clinicaltrials.gov ↗

RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease
Parkinson's Disease

Sponsor

Innopeutics Corporation